| 000 | 01805 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514002940.0 | ||
| 264 | 0 | _c20010802 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a0889-2229 | ||
| 024 | 7 |
_a10.1089/088922201750237022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDelgado, E | |
| 245 | 0 | 0 |
_aAnalysis of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: a UNAIDS study. _h[electronic resource] |
| 260 |
_bAIDS research and human retroviruses _cMay 2001 |
||
| 300 |
_a753-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Protease _xgenetics |
| 650 | 0 | 4 |
_aHIV Reverse Transcriptase _xgenetics |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPhylogeny |
| 650 | 0 | 4 |
_aProtease Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aVenezuela _xepidemiology |
| 700 | 1 | _aLeón-Ponte, M | |
| 700 | 1 | _aVillahermosa, M L | |
| 700 | 1 | _aCuevas, M T | |
| 700 | 1 | _aDeibis, L | |
| 700 | 1 | _aEcheverría, G | |
| 700 | 1 | _aThomson, M M | |
| 700 | 1 | _aPérez-Alvarez, L | |
| 700 | 1 | _aOsmanov, S | |
| 700 | 1 | _aNájera, R | |
| 773 | 0 |
_tAIDS research and human retroviruses _gvol. 17 _gno. 8 _gp. 753-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/088922201750237022 _zAvailable from publisher's website |
| 999 |
_c11358501 _d11358501 |
||